Fructose Malabsorption, Gut Microbiota and Clinical Consequences: A Narrative Review of the Current Evidence
Life · 06.11.2025 · 15 (11) · 1720
DOI: 10.3390/life15111720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 06.11.2025. Verfasst von Catarina D Simões und 3 weiteren Autor:innen. Beteiligte Einrichtung: FP-I3ID, Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fructose malabsorption is characterized as the incomplete absorption of fructose in the small intestine. Fructose is one of the most common monosaccharides in the human diet. The purpose of this review is to provide an updated overview of insights into the relationship between high-fructose diet, fructose malabsorption, gut microbiota and clinical consequences. Incomplete absorption of fructose causes accumulation in the colon, which leads to fermentation by gut microbiota and abdominal symptoms such as bloating and excessive gas production. Malabsorption may result from exceeding the absorptive capacity of GLUT5 or insufficient upregulation, with incidence increasing with age and higher dietary fructose concentrations. High-fructose diets generally promote an increase in inflammatory bacterial groups such as Desulfovibrio and Deferribacteraceae, while reducing beneficial Bacteroidetes. These microbial alterations may impair intestinal barrier function, modify short-chain fatty acid profiles, and contribute to systemic inflammation, metabolic disorders, and potentially mental health issues. Animal studies using fructose malabsorption models present inconclusive results regarding the impact of fructose on the composition of gut microbiota. Additional research is essential to fully comprehend the complex relationship between diet, fructose malabsorption and gut microbiota, to develop personalized, effective dietary approaches for managing symptoms of fructose malabsorption.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- FP-I3ID, Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.
- RISE-Health, Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.
- Center for Innovative Care and Health Technology (ciTechcare), Politécnico de Leiria, 2414-016 Leiria, Portugal.
- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
ORCID-Profile: Catarina D Simões, Ana Sofia Sousa, Amélia Sarmento
Zitieren
APA
Simões, C. D., Sousa, A. S., Fernandes, S., & Sarmento, A. (2025). Fructose Malabsorption, Gut Microbiota and Clinical Consequences: A Narrative Review of the Current Evidence. Life, 15(11), 1720. https://doi.org/10.3390/life15111720
Vancouver
Simões CD, Sousa AS, Fernandes S, Sarmento A. Fructose Malabsorption, Gut Microbiota and Clinical Consequences: A Narrative Review of the Current Evidence. Life. 2025;15(11):1720. doi:10.3390/life15111720
BibTeX
@article{Simes2025,
author = {Simões, Catarina D and Sousa, Ana Sofia and Fernandes, Sofia and Sarmento, Amélia},
title = {Fructose Malabsorption, Gut Microbiota and Clinical Consequences: A Narrative Review of the Current Evidence},
journal = {Life},
year = {2025},
volume = {15},
number = {11},
pages = {1720},
doi = {10.3390/life15111720}
}
EUVIMED